Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
23
pubmed:dateCreated
2002-12-5
pubmed:abstractText
The strategy of modulating gene activities in vivo via CRE/loxP recombination would greatly profit from subjecting the recombination event to an independent and stringent temporal control. Here, we describe a transgenic mouse line, LC-1, where the expression of the cre and luciferase gene is tightly controlled by the Tet system. Using the R26R mouse line as indicator for CRE activity, and mouse lines expressing tetracycline controlled transactivators (tTA/rtTA) in various tissues, we show that; (i) in the non-induced state CRE recombinase is tightly controlled throughout the development and adulthood of an animal; (ii) upon induction, efficient recombination occurs in the adult animal in all tissues where tTA/rtTA is present, including hepatocytes, kidney cells, neurons and T lymphocytes; and (iii) no position effect appears to be caused by the LC-1 locus. Moreover, using the novel rTA(LAP)-1 mouse line, we show that in hepatocytes, complete deletion of the loxP-flanked insert in R26R animals is achieved less than 48 h after induction. Thus, the LC-1 mouse appears suitable for exploiting two rapidly increasing collections of mouse lines of which one provides tTA/rtTA in specific cell types/tissues, and the other a variety of loxP-flanked genes.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-10545915, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-10608876, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-10689186, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-10859354, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-11044999, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-11087830, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-11252052, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-11584291, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-11590241, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-11857777, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-11948670, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-1319065, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-7567477, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-8139915, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-8559668, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-8698848, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-8855286, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-8939850, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-9878397, http://linkedlifedata.com/resource/pubmed/commentcorrection/12466566-9916792
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1362-4962
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e134
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Stringent doxycycline dependent control of CRE recombinase in vivo.
pubmed:affiliation
Zentrum für Molekulare Biologie der Universität Heidelberg, Im Neuenheimer Feld 282, D-69120 Heidelberg, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't